Squarepoint Ops LLC

Position in PRQR — ProQR Therapeutics N.V.

CIK 1642575 NEW YORK, NY

Position in PRQR

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$51,059

-$98,516 QoQ

Shares Held

31,518

-72.0% QoQ

Ownership

0.022%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

13 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Mar 31, 2026

Squarepoint Ops LLC holds $1,094,861,392 across 233 Biotechnology names. PRQR ranks #217 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	426,723	$141,189,839
2	REGN	Regeneron Pharmaceuticals, Inc.	162,814	$125,796,608
3	RPRX	Royalty Pharma plc	1,349,516	$64,736,282
4	IONS	Ionis Pharmaceuticals Inc	695,276	$52,208,274
5	BBIO	BridgeBio Pharma, Inc.	556,324	$41,312,620
6	MDGL	Madrigal Pharmaceuticals, Inc.	52,884	$27,683,187
7	ARQT	Arcutis Biotherapeutics, Inc.	1,103,490	$25,998,224
8	FOLD	AMICUS THERAPEUTICS, INC.	1,705,829	$24,666,287

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$51,059	31,518	-72.0%	Shares	Defined	2026-05-15
2025-03-31	$149,575	112,463	+35.3%	Shares	Defined	2025-08-27
2024-12-31	$220,252	83,114	+16.3%	Shares	Defined	2025-02-14
2024-09-30	$130,113	71,491	-15.6%	Shares	Defined	2024-11-14
2024-06-30	$140,656	84,733	-44.4%	Shares	Defined	2024-08-14
2024-03-31	$349,229	152,502	+19.0%	Shares	Defined	2024-05-15
2023-12-31	$253,784	128,174	-3.2%	Shares	Defined	2024-02-14
2023-09-30	$172,091	132,378	-1.3%	Shares	Defined	2023-11-14
2023-06-30	$217,310	134,142	+168.9%	Shares	Defined	2023-08-14
2022-03-31	$45,139	49,878	+176.3%	Shares	Defined	2022-05-16
2021-09-30	$151,070	18,049	-76.0%	Shares	Defined	2021-11-15
2021-03-31	$497,045	75,196	+279.7%	Shares	Defined	2021-05-17
2020-12-31	$83,181	19,805	—	Shares	Defined	2021-02-16
No filing history on record for this holder in this stock.